Ca in situ skin of the left upper limb, including the shoulder, refers to a localized malignant neoplasm that has not invaded deeper tissues. This condition is significant as it can progress to invasive cancer if not treated. The ICD-10 Code D04.62 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track and manage cases effectively.
ICD-10 Code D04.62 represents a diagnosis of carcinoma in situ of the skin located on the left upper limb, including the shoulder. This condition is characterized by abnormal cells that have not spread beyond the original site. The code is used in clinical documentation and billing when a patient presents with this specific diagnosis, ensuring proper coding for treatment and management.
Ca in situ skin of the left upper limb, including shoulder, is primarily caused by prolonged exposure to ultraviolet radiation, leading to cellular changes in the skin. It is crucial to address this condition promptly to prevent progression to invasive cancer.
ICD-10 Code D04.62 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It is relevant in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition.
In SOAP notes, ICD-10 Code D04.62 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis. This code is essential for ensuring continuity of care, supporting billing processes, and meeting EHR documentation standards.
Prompt treatment of Ca in situ skin of the left upper limb, including shoulder, is essential to prevent progression to invasive cancer.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D04.62 is critical in medical billing, particularly in hospital, ER, or outpatient settings.
| CPT Code | Description |
|---|---|
| 99213 | Established patient office visit, level 3. |
| 11100 | Biopsy of skin, subcutaneous tissue, or mucous membrane. |
| 17000 | Destruction of benign lesions, first lesion. |
Common Questions About Using ICD-10 Code D04.62 for Ca in situ skin of left upper limb, including shoulder
What are the treatment options for Ca in situ skin?
Treatment options include topical chemotherapy, cryotherapy, and surgical excision. The choice of treatment depends on the lesion's characteristics and patient preferences.
How is Ca in situ skin diagnosed?
Diagnosis is typically made through clinical examination and confirmed by biopsy, which reveals atypical keratinocytes confined to the epidermis.
Is Ca in situ skin contagious?
No, Ca in situ skin is not contagious. It is a localized skin condition resulting from cellular changes, primarily due to UV exposure.
What follow-up care is necessary for Ca in situ skin?
Regular follow-up appointments are essential to monitor for any changes in the lesion and to educate patients on skin protection and self-examinations.
Clinical Notes
SOAP notes
DAP notes
AI medical notes